Arrowhead Pharmaceuticals Market Cap

Arrowhead Pharmaceuticals has a market cap or net worth of $2.51 billion as of February 21, 2025. Its market cap has decreased by -27.05% in one year.

Market Cap

2.51B

Enterprise Value

2.83B

1-Year Change

-27.05%

Ranking

#1799

Market Cap Chart

Since June 30, 2004, Arrowhead Pharmaceuticals's market cap has increased from $95.40M to $2.51B, an increase of 2,530.35%. That is a compound annual growth rate of 17.15%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	2.64B	12.98%
Dec 31, 2024	2.34B	-28.84%
Dec 29, 2023	3.29B	-23.54%
Dec 30, 2022	4.30B	-37.84%
Dec 31, 2021	6.92B	-11.95%
Dec 31, 2020	7.86B	29.67%
Dec 31, 2019	6.06B	451.13%
Dec 31, 2018	1.10B	299.42%
Dec 29, 2017	275.20M	154.58%
Dec 30, 2016	108.10M	-70.48%
Dec 31, 2015	366.20M	-9.27%
Dec 31, 2014	403.60M	-3.88%
Dec 31, 2013	419.90M	1,153.43%
Dec 31, 2012	33.50M	-24.04%
Dec 30, 2011	44.10M	-31.42%
Dec 31, 2010	64.30M	93.09%
Dec 31, 2009	33.30M	-15.70%
Dec 31, 2008	39.50M	-72.93%
Dec 31, 2007	145.90M	-2.60%
Dec 29, 2006	149.80M	25.99%
Dec 30, 2005	118.90M	101.87%
Dec 31, 2004	58.90M	-38.26%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings